Alterations in expression pattern of splicing factors in epithelial ovarian cancer and its clinical impact.

Int J Gynecol Cancer 2013 Jul;23(6):990-6

Gynecological Hospital, Freiburg University Medical Center, Hugstetterstrasse 55, Freiburg, Germany.

Objective: Alternative splicing represents an important nuclear mechanism in the posttranscriptional regulation of gene expression, which is frequently altered during tumorigenesis. Previously, we described marked changes in alternative splicing of the CD44 gene in ovarian and breast cancer as well as specific induction of distinct splicing factors during tumor development. The present study was focused on the expression profiles of different splicing factors, including classical serine-arginine (SR) proteins including ASF/SF2, hTra2β1, hTra2α, and Y-box-binding protein (YB-1) in physiological and malignant epithelial ovarian tissue to evaluate their expression pattern with regard to tumor development and disease progression.

Materials And Methods: Expression levels of the different splicing factors were analyzed in physiological epithelial ovarian tissue samples, primary tumors, and metastatic samples of patients with a diagnosis of epithelial ovarian cancer using quantified reverse transcription polymerase chain reaction analysis. We examined more closely the splicing factor hTra2β1 using Western blot analysis and immunohistochemistry.

Results: The analysis revealed a marked and specific induction of ASF/SF2, SRp20, hTra2β1, and YB-1 in primary tumors as well as in their metastatic sites. However, in our patient cohort, no induction was seen for the other investigated splicing factors SRp55, SRp40, and hTra2α.

Conclusions: Our results suggest a specific induction of distinct splicing factors in ovarian cancer tumorigenesis. The involvement of hTra2β1, YB-1, SRp20, and ASF/SF2 in exon recognition and alternative splicing may be important for gene regulation of alternatively spliced genes like CD44 with potential functional consequences in this tumor type leading to progression and metastasis.

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e31829783e3DOI Listing
July 2013
16 Reads

Publication Analysis

Top Keywords

splicing factors
24
epithelial ovarian
16
ovarian cancer
12
alternative splicing
12
specific induction
12
splicing
10
distinct splicing
8
tumor development
8
primary tumors
8
htra2β1 yb-1
8
induction distinct
8
expression pattern
8
ovarian tissue
8
ovarian
6
factors
6
quantified reverse
4
cancer quantified
4
reverse transcription
4
chain reaction
4
polymerase chain
4

References

(Supplied by CrossRef)

Modrek et al.
Nat Genet 2002

Buratti et al.
Nucleic Acids Res 2006

Philips et al.
Cell Mol Life Sci 2000

Stoilov et al.
DNA Cell Biol 2002

Venables et al.
Cancer Res 2004

Hui et al.
Oncogene 2004

Faustino et al.
Genes Dev 2003

Graveley et al.
RNA 2000

Fu et al.
RNA 1995

Lin et al.
Adv Exp Med Biol 2007

Stickeler et al.
Oncogene 1999

Similar Publications